CARDINAL HEALTHCARE recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials
Recalled January 3, 2024 · FDA recall D-0161-2024 · CARDINAL HEALTHCARE
Hazard
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. · FDA Class II
Units
2 cartons
Sold at
Nationwide USA
Description
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Product
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials (2 pouches of 30 - 3 mL vials each), Manufactured By: The Ritedose Corporation, Columbia, SC 29203; Distributed By: Cipla USA Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-840-64
Manufacturer(s)
CARDINAL HEALTHCARE
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →